EndoSure, Inc.

First non-invasive diagnostic test for endometriosis. FDA cleared and currently available.

  • Stage Product In Market
  • Industry Medical Devices and Equipment
  • Location Sparks Glencoe, MD, USA
  • Currency USD
  • Founded July 2022
  • Employees 3
  • Incorporation Type C-corp
  • Website endosure.com

Company Summary

EndoSure, Inc. provides disruptive technology for non-invasive, highly accurate, instant, diagnosis of endometriosis performed in 30 minutes. The EndoSure Test is the only diagnostic for detecting all stages of endometriosis. This allows for early diagnosis before disease progression.

Until now, the average time to diagnose endometriosis was over eight years and the gold standard was invasive laparoscopic surgery.

Team

  • Crystal Hernandez
    COO

    10 years experience in operations at multiple medical and medical device organizations

  • Mark Noar
    Founder, Inventor

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free